Clinical Trial Update: Anti BCMA CAR- T Cell Therapy for Adults With Relapsed or Refractory Multiple Myeloma [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial update for an anti-BCMA CAR-T cell therapy in adults with relapsed or refractory multiple myeloma; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Anti-BCMA CAR-T cell therapy

Snippet

Sponsor: Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology | Conditions: Multiple Myeloma Refractory | Phase 1, Phase 2 | Status: RECRUITING